| Overview |
| bs-0631r-pe-100ul |
| TXLNG Polyclonal Antibody, PE Conjugated |
| WB |
| Human, Mouse |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human TXLNG |
| 466-528/528 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| Q9NUQ3 |
| Cytoplasm, Nucleus, Cell membrane |
| chromosome X open reading frame 15; LSR5; CXorf15; Environmental lipopolysaccharide-responding gene protein; factor inhibiting activating transcription factor 4 ATF4-mediated transcription; Factor inhibiting ATF4-mediated transcription antibody FIAT; Gamma-taxilin; Lipopolysaccharide-specic response protein 5; LSR5; TXLNG; TXLNG_HUMAN. |
| This gene encodes a member of the taxilin family. The encoded protein binds to the C-terminal coiled-coil region of syntaxin family members 1A, 3A and 4A, and may play a role in intracellular vesicle trafficking. This gene is up-regulated by lipopolysaccharide and the gene product may be involved in cell cycle regulation. The related mouse protein was also shown to inhibit activating transcription factor 4-mediated transcription and thus regulate bone mass accrual. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz